Table 2

Summary of the 16 Studies Reviewed

Design

Intervention

Country

Focus

Sample

Sample size

(n)

Duration

Reference


Cluster blind RCT

Electronic decision support system

USA

GP

T1D, T2D

639

21 months

[15]

Cluster RCT

Diabetes register

UK

GP

T2D

3, 608

15 months

[16]

Cluster RCT

Diabetes register

USA

GP

T2D

7, 101

12 months

[17]

Cluster RCT

Electronic telemedicine

USA

Patient

T2D

1, 665

12 months

[18]

Cluster RCT

Electronic telemedicine

USA

GP

T2D

1, 665

12 months

[19]

Cluster RCT

Electronic self-management system

USA

Patient

T2D

886

12 months

[20]

RCT

Electronic self-management system

USA

Patient

T1D, T2D

122

6 months

[21]

RCT

Electronic self-management system

USA

Patient

T1D, T2D

104

12 months

[22]

RCT

Electronic self-management system

USA

Patient

T1D, T2D

62

6 months

[23]

Nonrandomised cluster control trial

Electronic management system

USA

GP

T1D, T2D

6, 646

24 months

[24]

Nonrandomised control trial

Diabetes register

USA

GP

T1D, T2D

898

20 months

[25]

Nonrandomised control trial

Personal Digital Assistant (PDA) based electronic management system

USA

GP

T2D

173

16 months

[26]

Nonrandomised control trial

Diabetes register

USA

GP

T1D, T2D

661

2 years

[27]

Nonrandomised control trial

Electronic decision support system

USA

GP

T1D, T2D

16

6 months

[28]

Single sample before and after design

Diabetes register

USA

GP

T1D, T2D

62

3 years

[29]

Single sample before and after design

Diabetes register

Korea

GP

T1D, T2D

185

3 months

[30]


Note. RCT = randomised control trial; GP = general practitioner; T1D = type 1 diabetes; T2D = type 2 diabetes.

Costa et al. BMC Family Practice 2009 10:72   doi:10.1186/1471-2296-10-72

Open Data